Get the Stockscreener App
3.14
3.68%
-0.12
Pre-market:
3.16
0.02
+0.64%
Lixte Biotechnology Holdings Inc Stock (LIXT) Forecast
The Lixte Biotechnology Holdings Inc (LIXT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.6968, representing a -45.96% decrease from the current price of $3.14. The highest analyst price target is $2.1548, and the lowest is $1.2388.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LIXT Price Target
Average 1.8675
(-40.53% Downside)
Is Lixte Biotechnology Holdings Inc (LIXT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.82 | Neutral |
| STOCH(9,6) | 25.27 | Neutral |
| STOCHRSI(14) | 10.41 | Buy |
| MACD(12,26) | 0.1102 | Sell |
| ADX(14) | 37.67 | Buy |
| William %R | -91.84 | Buy |
| CCI(14) | -193.70 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.3116
Sell
|
3.2667
Sell
|
| MA20 |
3.3338
Sell
|
3.2154
Sell
|
| MA50 |
2.8468
Buy
|
2.9427
Buy
|
| MA100 |
2.5069
Buy
|
2.7354
Buy
|
| MA200 |
2.6431
Buy
|
2.4799
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, LIXT could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 6 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on LIXT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 49.82 indicates that LIXT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.27 indicates that LIXT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.41 indicates that LIXT is oversold. This suggests that LIXT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.67 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -193.7 indicates that LIXT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term LIXT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lixte Biotechnology Holdings Inc financial reports and earnings history, Lixte Biotechnology Holdings Inc (LIXT) stock could reach $0.8207 by 2030, $5.4551 by 2040 and $10.21 by 2050. See the projected annual prices until 2050 of the Lixte Biotechnology Holdings Inc stock below:
- Lixte Biotechnology Holdings Inc (LIXT) is expected to reach an average price of $4.0975 in 2035, with a high prediction of $4.0409 and a low estimate of $4.1352. This indicates an $30.49% rise from the last recorded price of $3.14.
- Lixte Biotechnology Holdings Inc (LIXT) stock is projected to chart a bullish course in 2040, with an average price target of $5.5225, representing an $75.88% surge from its current level. The forecast ranges from a conservative $5.297 to a sky-high $5.4551.
- Our analysts predict Lixte Biotechnology Holdings Inc (LIXT) to jump 137.08% by 2045, soaring from $7.4668 to an average price of $7.4443, potentially reaching $7.4471. While $7.4668 is the low estimate, the potential upside is significant.
- Lixte Biotechnology Holdings Inc (LIXT) stock is expected to climb by 2050, reaching an average of $10.28, a $227.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.21 and $10.05, respectively, highlighting the market's uncertainty.
Lixte Biotechnology Holdings Inc Stock (LIXT) Year by Year Forecast
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2024
Our forecast for LIXT stock price in 2024 now indicates an average price target of $1.7079 with a high forecast of $3.3035 and a low forecast of $0.1123. The average prediction reflects an decrease of -45.61% from the last recorded price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $1.3888 | $1.2388 | $2.1548 | -55.77% |
| June, 2024 | $0.8932 | $0.6921 | $2.716 | -71.56% |
| July, 2024 | $0.7711 | $0.7211 | $1.5039 | -75.44% |
| August, 2024 | $0.4354 | $0.3854 | $0.8247 | -86.13% |
| September, 2024 | $0.4833 | $0.399 | $0.7797 | -84.61% |
| October, 2024 | $0.1123 | $0.1123 | $0.5369 | -96.42% |
| November, 2024 | $0.128 | $0.1147 | $0.4912 | -95.92% |
| December, 2024 | $0.6399 | $0.1543 | $1.7856 | -79.62% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2025
Lixte Biotechnology Holdings Inc Stock (LIXT) is expected to reach an average price of $1.8675 in 2025, with a high prediction of $3.6965 and a low estimate of $0.0385. This indicates an -40.53% fall from the last recorded price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.2142 | $0.0758 | $0.7535 | -93.18% |
| February, 2025 | $0.00858 | $0.0385 | $0.4878 | -99.73% |
| March, 2025 | $0.3165 | $0.0478 | $3.6965 | -89.92% |
| April, 2025 | $0.2883 | $0.1028 | $0.4872 | -90.82% |
| May, 2025 | $0.3947 | $0.4637 | $0.4484 | -87.43% |
| June, 2025 | $0.4713 | $0.4858 | $0.437 | -84.99% |
| July, 2025 | $0.4406 | $0.4162 | $0.4033 | -85.97% |
| August, 2025 | $0.4083 | $0.4283 | $0.3585 | -87.00% |
| September, 2025 | $0.6603 | $0.4611 | $0.4803 | -78.97% |
| October, 2025 | $0.626 | $0.6132 | $0.5496 | -80.06% |
| November, 2025 | $0.6317 | $0.6553 | $0.5917 | -79.88% |
| December, 2025 | $0.4913 | $0.3673 | $0.5195 | -84.35% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2026
The predicted value for Lixte Biotechnology Holdings Inc (LIXT) in 2026 is set at an average of $4.326. Estimates vary from a peak of $8.5117 to a trough of $0.1403, indicating an +37.77% surge from the present price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5594 | $0.6192 | $0.578 | -82.18% |
| February, 2026 | $0.2951 | $0.3541 | $0.4958 | -90.60% |
| March, 2026 | $0.1597 | $0.1403 | $1.6221 | -94.91% |
| April, 2026 | $0.201 | $0.2742 | $0.2564 | -93.60% |
| May, 2026 | $0.3805 | $0.2227 | $0.3416 | -87.88% |
| June, 2026 | $0.3106 | $0.4229 | $0.4213 | -90.11% |
| July, 2026 | $4.9037 | $0.4429 | $5.7481 | +56.17% |
| August, 2026 | $3.2117 | $3.0617 | $8.5117 | +2.28% |
| September, 2026 | $1.546 | $1.276 | $3.7452 | -50.76% |
| October, 2026 | $1.5503 | $1.2832 | $1.7803 | -50.63% |
| November, 2026 | $1.8082 | $0.6311 | $2.0082 | -42.41% |
| December, 2026 | $1.5426 | $0.999 | $1.9818 | -50.87% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lixte Biotechnology Holdings Inc (LIXT) is $1.7647, with a high forecast of $3.5105 and a low forecast of $0.019. This indicates an -43.80% decrease from the last price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0469 | $1.6062 | $2.5597 | -34.81% |
| February, 2027 | $1.2112 | $1.0012 | $3.5105 | -61.43% |
| March, 2027 | $0.3915 | $0.1915 | $1.8171 | -87.53% |
| April, 2027 | $0.2798 | $0.1537 | $0.683 | -91.09% |
| May, 2027 | $0.044 | $0.324 | $0.806 | -98.60% |
| June, 2027 | $0.0547 | $0.0197 | $0.2875 | -98.26% |
| July, 2027 | $0.3033 | $0.019 | $0.4062 | -90.34% |
| August, 2027 | $0.5608 | $0.0605 | $1.312 | -82.14% |
| September, 2027 | $0.3422 | $0.4722 | $0.4337 | -89.10% |
| October, 2027 | $0.6635 | $0.555 | $0.5535 | -78.87% |
| November, 2027 | $0.8177 | $0.6863 | $0.7548 | -73.96% |
| December, 2027 | $1.0204 | $0.8205 | $0.8989 | -67.50% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2028
In 2028, Lixte Biotechnology Holdings Inc (LIXT) is projected to reach an average price of $1.5823, with a high projection of $2.443 and a low estimate of $0.7217. This indicates an -49.61% fall from the last price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.4032 | $1.0718 | $1.2931 | -55.31% |
| February, 2028 | $0.7445 | $0.7217 | $1.346 | -76.29% |
| March, 2028 | $0.7258 | $0.7456 | $0.6602 | -76.88% |
| April, 2028 | $1.2072 | $1.1487 | $0.8772 | -61.56% |
| May, 2028 | $1.3213 | $1.3157 | $1.2913 | -57.92% |
| June, 2028 | $1.3127 | $1.3827 | $2.443 | -58.20% |
| July, 2028 | $1.7063 | $1.3455 | $1.6768 | -45.66% |
| August, 2028 | $1.626 | $1.707 | $1.6101 | -48.22% |
| September, 2028 | $1.5795 | $1.6394 | $1.6439 | -49.70% |
| October, 2028 | $1.6017 | $1.6123 | $1.5475 | -48.99% |
| November, 2028 | $1.615 | $1.6065 | $1.5513 | -48.57% |
| December, 2028 | $1.741 | $1.6631 | $1.7035 | -44.55% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2029
The 2029 price forecast for Lixte Biotechnology Holdings Inc Stock (LIXT) is $3.9127 on average, with a high prediction of $7.5233 and a low estimate of $0.302. This represents an +24.61% increase from the previous price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.768 | $1.7892 | $1.7294 | -43.69% |
| February, 2029 | $1.4768 | $1.6618 | $1.7233 | -52.97% |
| March, 2029 | $1.7132 | $1.4847 | $1.5932 | -45.44% |
| April, 2029 | $1.4463 | $1.5772 | $1.681 | -53.94% |
| May, 2029 | $1.0187 | $1.2147 | $1.3702 | -67.56% |
| June, 2029 | $1.405 | $1.3043 | $1.27 | -55.25% |
| July, 2029 | $1.454 | $1.2683 | $1.3128 | -53.69% |
| August, 2029 | $1.4155 | $1.455 | $1.4527 | -54.92% |
| September, 2029 | $1.3568 | $1.4435 | $1.3633 | -56.79% |
| October, 2029 | $3.099 | $2.6075 | $5.1747 | -1.31% |
| November, 2029 | $1.5577 | $1.2605 | $7.5233 | -50.39% |
| December, 2029 | $0.5785 | $0.302 | $1.8544 | -81.58% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2030
Lixte Biotechnology Holdings Inc Stock (LIXT) is expected to reach an average price of $1.3345 in 2030, with a high forecast of $2.601 and a low forecast of $0.068. This signifies an -57.50% decrease from the last price of $3.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0378 | $0.125 | $0.8207 | -98.79% |
| February, 2030 | $0.5008 | $0.0758 | $1.0665 | -84.05% |
| March, 2030 | $0.9095 | $0.068 | $1.6395 | -71.04% |
| April, 2030 | $0.2997 | $0.2451 | $2.601 | -90.45% |
| May, 2030 | $0.0893 | $0.1025 | $0.4397 | -97.16% |
| June, 2030 | $1.1063 | $0.8485 | $1.0281 | -64.77% |
| July, 2030 | $1.5425 | $1.2555 | $1.754 | -50.88% |
| August, 2030 | $1.3995 | $1.6295 | $1.4403 | -55.43% |
| September, 2030 | $1.0658 | $1.2658 | $1.2428 | -66.06% |
| October, 2030 | $1.4728 | $1.3543 | $1.2589 | -53.10% |
| November, 2030 | $1.9798 | $1.892 | $1.8305 | -36.95% |
| December, 2030 | $2.016 | $1.8583 | $1.926 | -35.80% |
1.51%
Cap:
|
Volume (24h):